ClinicalTrials.Veeva

Menu

Antipsychotic Polypharmacy: Prevalence, Background and Consequences

G

Glostrup University Hospital, Copenhagen

Status

Completed

Conditions

Schizophrenia

Treatments

Behavioral: Implementation of guideline

Study type

Interventional

Funder types

Other

Identifiers

NCT00541398
0-204-03-9-9

Details and patient eligibility

About

The primary purpose of the study is to investigate whether an intensive educational intervention can reduce the use of antipsychotic polypharmacy. It is hypothesised that the use of antipsychotic polypharmacy is, in some degree, dependent on non-patient related factors.

Full description

Several surveys have shown a high prevalence of antipsychotic polypharmacy (concomitant prescription of at least 2 different antipsychotics) among patients with schizophrenia even though international guidelines recommend monotherapy.

From register data areas with differences in the prevalence of antipsychotic polypharmacy will be identified. Two high prevalence areas will be randomized to either control or intervention area. In the intervention area an intensive educational intervention consisting of outreach visits with a multifaceted approach will be carried out with the duration of 1 year.

Differences in health staff related factors such as knowledge and attitude towards clinical guidelines will be assessed with a questionnaire before and after the intervention in the intervention area as well as in the low prevalence area at baseline.

Medical records data describing the use of antipsychotic polypharmacy will be collected. With register data health economic issues will be assessed.

Enrollment

222 estimated patients

Sex

All

Ages

18 to 64 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • The intervention is not aimed directly to the patients but their health care providers.
  • Patients with schizophrenia (F2* diagnosis according to ICD-10) taking antipsychotic medication and their health care providers in the specified areas will enter the study:
  • The patients will enter with data from their medical record, register data and a few exploring interviews while the health staff will enter with their questionnaire data.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

222 participants in 2 patient groups

A
Experimental group
Treatment:
Behavioral: Implementation of guideline
B
No Intervention group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems